Viewing Study NCT00918957


Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2026-01-25 @ 5:43 PM
Study NCT ID: NCT00918957
Status: COMPLETED
Last Update Posted: 2012-10-03
First Post: 2009-06-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cystic Fibrosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tobramycin Inhalation Powder View
None Cystic fibrosis View
None Lung diseases View
None Anti-Bacterial Agents View
None Treatment of infections with P. aeruginosa in cystic fibrosis subjects View